CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 345 enrolled
Drug / intervention
SPARKother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03593525
NCT03593525N/ACompleted

A Randomized Controlled Trial of Symptom Screening by Children With Cancer and Feedback to Providers

The Hospital for Sick Children·interventional·Posted Jul 20, 2018·Updated Aug 8, 2025

In Brief

A clinical study evaluating SPARK for Pediatric Oncology and Quality of Life. Completed, enrolled 345 participants across 1 site.

Detailed Summary

Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK) is a web-based application which builds upon the Symptom Screening in Pediatrics Tool (SSPedi) and consists of two components: (1) a symptom screening component centered on SSPedi; and (2) a supportive care clinical practice guideline (CPG) component. This proposal is a randomized controlled trial that compares daily completion of SSPedi via SPARK for 5 days with symptom feedback to healthcare providers compared with standard of care

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 20, 2018
Enrollment StartSep 1, 2018
Primary CompletionSep 16, 2023
Study CompletionSep 17, 2023
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 8.0 years ago

Interventions

SPARKother

see above